Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
118.18B
Market cap118.18B
Price-Earnings ratio
23.18
Price-Earnings ratio23.18
Dividend yield
3.03%
Dividend yield3.03%
Average volume
9.02M
Average volume9.02M
High today
$93.30
High today$93.30
Low today
$91.42
Low today$91.42
Open price
$92.77
Open price$92.77
Volume
7.97M
Volume7.97M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

With a market cap of 118.18B, Medtronic(MDT) trades at $92.39. The stock has a price-to-earnings ratio of 23.18 and currently yields dividends of 3.03%.

On 2026-09-08, Medtronic(MDT) stock moved within a range of $91.42 to $93.30. With shares now at $92.39, the stock is trading +1.1% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 7.97M, compared to an average daily volume of 9.02M.

The stock's 52-week range extends from a low of $73.31 to a high of $106.33.

The stock's 52-week range extends from a low of $73.31 to a high of $106.33.

MDT News

Zacks 9h
Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated? - Zacks Investment Research

...

Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated? - Zacks Investment Research
Nasdaq 9h
Medtronic Q1 2027 Earnings Call Transcript

Medtronic (MDT) Q1 2027 Earnings Call Transcript The Motley Fool Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a mul...

Medtronic Q1 2027 Earnings Call Transcript
Benzinga 9h
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%

More MDT News

TipRanks 10h
Medtronic: Buy Rating Reaffirmed as Analyst Sees M&A-Driven Upside with Unchanged $110 Price Target

Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic and keeping the price target at $110.00. Travis Steed has given his B...

Simply Wall St 4d
Is Medtronic’s US$700 Million Robotics Push With Cornerstone Reshaping The Investment Case For MDT?

In early September 2026, Medtronic reported first-quarter sales of US$9,756 million and net income of US$1,470 million, announced a roughly US$700 million partn...

Is Medtronic’s US$700 Million Robotics Push With Cornerstone Reshaping The Investment Case For MDT?
TipRanks 5d
Dividend Aristocrat Stocks PEP and MDT Attract 10%+ Upside Targets Ahead of Key September Dates

Analysts see at least 10% upside in dividend aristocrat stocks PepsiCo (PEP) and Medtronic (MDT). This matters as the companies have ex-dividend dates of Friday...

TipRanks 5d
Medtronic’s PERSIST Study Builds Real-World Evidence for Inceptiv SCS and Investor Confidence

Medtronic (MDT) announced an update on their ongoing clinical study. The PERSIST addendum study, officially titled “Post Market Evaluation of Real World Outcom...

TipRanks 5d
Medtronic price target raised to $92 from $78 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Medtronic (MDT) to $92 from $78 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate...

TipRanks 6d
Medtronic price target raised to $115 from $100 at Mizuho

Mizuho analyst Anthony Petrone raised the firm’s price target on Medtronic (MDT) to $115 from $100 and keeps an Outperform rating on the shares. Cardiovascular...

Benzinga 6d
Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection

Shares of Medtronic PLC (NYSE:MDT) rose in early trading on Wednesday, after the company reported upbeat fiscal first-quarter results. Here are some key analys...

Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.